Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Post by heavymomentumon Feb 03, 2019 10:31am
63 Views
Post# 29311697

Canada can open market to edibles at any moment

Canada can open market to edibles at any moment
https://www.investopedia.com/new-cannabis-products-which-could-disrupt-the-industry-in-2019-4586411

"Companies like GW Pharmaceuticals (GWPH) and Cara Therapeutics (CARA) are rushing to develop and test new CBD-based drug treatments."

You would have to be completely ignorant if you think GW and CARA are the only two who can generate new unknown products. The ability of companies like ISOL can and will supply the cannabidiol as required.
Bullboard Posts